Home » Clinical Trials » Search Clinical Trials

Therapeutic Areas: Oncology

Soft Tissue Sarcoma Clinical Trials

A listing of Soft Tissue Sarcoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35243

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Arizona

Tucson Arizona

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

California

Duarte California 91010-0269

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating MGA271 plus Ipilimumab for the treatment of Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer

Los Angeles California 90024

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

San Francisco California 94115

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Santa Monica California 90404

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

View More ▼

Santa Monica California 90403

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Santa Monica California 90403

A clinical trial seeking patients for a research study for the treatment of Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma

Stanford California 94305

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Colorado

Aurora Colorado 80045

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Connecticut

New Haven Connecticut

Patients are needed to participate in a clinical research study evaluating MGA271 plus Ipilimumab for the treatment of Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer

Florida

Jacksonville Florida 32224

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Jacksonville Florida 32224

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Miami Florida 33136

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Georgia

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Atlanta Georgia 30341

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Iowa

Iowa City Iowa

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Iowa City Iowa 52242

Patients are needed to participate in a clinical research study evaluating Talimogene Laherparepvec and Radiotherapy for the treatment of Soft Tissue Sarcoma

Kentucky

Louisville Kentucky 40202

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Maryland

Baltimore Maryland 21218

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Baltimore Maryland 21201

Patients are needed to participate in a clinical research study of MGA271 and Pembrolizumab to evaluate Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer, Refractory Cancer

Massachusetts

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Michigan

Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Minnesota

Rochester Minnesota 55905

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Missouri

St. Louis Missouri 63130

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Nebraska

Omaha Nebraska 68114

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Omaha Nebraska 68114

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

New Mexico

Albuquerque New Mexico 87102

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

New York

Buffalo New York 92122

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Lake Success New York 11042

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

New York New York 10032

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

New York New York 10065

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

New York New York 10029

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

View More ▼

New York New York 10032

Patients are needed to participate in a clinical research study evaluating MGA271 plus Ipilimumab for the treatment of Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer

New York New York 10032

Patients are needed to participate in a clinical research study of MGA271 and Pembrolizumab to evaluate Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer, Refractory Cancer

New York New York 10065

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

North Carolina

Charlotte North Carolina 28204

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Durham North Carolina 27710

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Ohio

Cincinnati Ohio 45242

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Oregon

Portland Oregon 97213

Patients are needed to participate in a clinical research study evaluating MGA271 plus Ipilimumab for the treatment of Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer

Portland Oregon 97239

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Pennsylvania

Philadelphia Pennsylvania 19104

Patients are needed to participate in a clinical research study of MGA271 and Pembrolizumab to evaluate Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer, Refractory Cancer

Philadelphia Pennsylvania 19106

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

South Carolina

Spartanburg South Carolina 29303

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Tennessee

Germantown Tennessee 38138

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Nashville Tennessee 37203

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Nashville Tennessee 37203

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma